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OBJECTIVES The purpose of the present study was to systematically evaluate the diagnostic utility of
mechanical, pharmacological and orthostatic stimulation of the carotid sinus in a consecutive
series of patients with recurrent unexplained syncope.
BACKGROUND Carotid sinus hypersensitivity (CSH) is an infrequently recognized cause of recurrent
unexplained syncope usually diagnosed by carotid sinus massage (CSM) in the supine
position. The diagnostic utility of systematic assessment of mechanical, pharmacological and
orthostatic stimulation of the carotid sinus has not been clearly established.
METHODS Eighty consecutive patients (63 6 12 years) with a history of recurrent unexplained syncope
(mean episodes: 6 6 3); 30 age-matched controls (65 6 14 years) and 16 patients (59 6 12
years) with syncope not related to CSH were studied. Pharmacological stimulation of the
carotid sinus was achieved by randomly administering bolus injections of nitroprusside and
phenylephrine. Mechanical stimulation of the carotid sinus was performed by CSM applied
for 5 s in the supine position and after 2 min at 60°. A 60° low-dose isoproterenol head-up
tilt test (HUTT) was also performed for a total duration of 30 min.
RESULTS Carotid sinus hypersensitivity was elicited by CSM in the supine position in seven (8.7%)
patients, two (6.6%) controls and one (6.3%) patient with syncope unrelated to CSH,
compared with 48 (60%) patients, two (6.6%) controls and one (6.3%) syncope unrelated to
CSH patient after 60° HUTT, increasing the diagnostic yield by 51%. Baroreceptor gain was
significantly reduced in the CSH group. Head-up tilt test was positive in 12 (25%) patients
with CSH, two (6.6%) controls and two (12%) with documented syncope but not positive in
any of the patients in which syncope remained unexplained. Diagnostic accuracy was
enhanced by 38% (31% supine vs. 69% upright) when CSM was performed at 60°.
CONCLUSIONS CSH was documented in 68% of patients, 8.7% in the supine position and 60% in the upright
position. Sensitivity was increased by 51%, and diagnostic accuracy was enhanced by 38% by
performing CSM in the upright position. Decreased baroreceptor gain was documented and
may play a role in the pathophysiology of CSH. (J Am Coll Cardiol 1999;34:1587–94) ©
1999 by the American College of Cardiology
The incidence of carotid sinus hypersensitivity (CSH) as a
cause of unexplained syncope is unclear and may be under-
estimated particularly in elderly patients (1–6). Morley et al.
(1) estimated that the number of newly diagnosed cases of
CSH associated with syncope or presyncope is 35 per
million population per year. Carotid sinus hypersensitivity is
usually diagnosed by eliciting significant bradycardia and/or
hypotension associated with presyncope or syncope, during
carotid sinus massage (CSM) usually performed in the
supine position. However, the relevance of provoking sig-
nificant bradycardia/hypotension during CSM may be lim-
ited by the lack of standardization of this method. Similarly,
the effect of orthostatic stress during carotid sinus stimula-
tion has not been systematically assessed. Given the fact that
CSH is a form of neurally mediated syncope, it appears
pertinent to assess the effects of orthostatic stress during
CSM in patients with recurrent unexplained syncope.
The purpose of the present study was to systematically
assess the diagnostic utility of mechanical, pharmacological
and orthostatic stimulation of the carotid sinus of patients
with unexplained syncope and compare it with a control
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group with no previous history of syncope and a group with
documented causes of syncope not related to CSH.
METHODS
Study population. Eighty consecutive patients aged 46 to
85 years (mean 63 6 12 years) with a history of two or more
syncopal episodes in the preceding 6 months and 30
age-matched controls 48 to 89 years (mean 65 6 14 years)
with no history of syncope or presyncope were studied.
Additionally, 16 subjects aged 31 to 74 years (mean 59 6 12
years) with syncope not related to CSH (12 ventricular
tachycardia/ventricular fibrillation [VT/VF], two complete
AV block, two severe sinus node dysfunction) underwent
the same study protocol. All patients underwent complete
physical and neurological examination as well as 12-lead
electrocardiogram (ECG), 24- to 48-h ambulatory ECG
monitoring and a two-dimensional echocardiogram. Addi-
tionally, all 16 subjects with syncope not related to CSH
underwent complete electrophysiologic evaluation. Verbal
and written informed consent was obtained in all patients.
Carotid sinus stimulation protocol. All subjects were
studied in the postabsortive state between 8:30 AM and
12:00 noon. An intravenous line was inserted, and 5%
dextrose in normal saline was begun at a rate of 30 ml/h.
Patients were allowed 15 min for stabilization and data
acquisition. Continuous noninvasive assessment of blood
pressure (Ohmeda 2300; Finapress) and ECG lead II were
recorded by CAFTS system (MEDIKRO, Finland) and
simultaneously saved on the hard drive of a personal
computer for further data analysis.
Pharmacological stimulation. Pharmacological stimula-
tion of the carotid sinus was achieved by randomly admin-
istering a bolus injection of 100 mg of nitroprusside followed
after 60 s by 150 mg of phenylephrine (7). Five to 10 min
were allowed for restoration of baseline parameters, and the
procedure was repeated after reversing the order of the bolus
injections. The maximum change in heart rate and systolic
and diastolic blood pressure with both vasoactive agents was
calculated and compared within groups. Baroreceptor reflex
slope was calculated by plotting each R-R interval as a
function of the preceding systolic blood pressure, and
beat-by-beat analysis was performed when R-R interval
changed. A least-squares-fit linear regression was per-
formed, and reflex control of heart rate was expressed as the
slope of the linear regression line. Only slopes with regres-
sion coefficient $0.7 were accepted for analysis. Slopes were
calculated for both nitroprusside and phenylephrine infu-
sion as well as for the whole range of R-R intervals and
systolic blood pressures during both infusions (7).
Mechanical stimulation. Five minutes for recovery was
allowed after the pharmacological interventions, and CSM
was performed by gently applying pressure over the carotid
sinus for a period of 5 s initially on the right side. This
procedure was repeated at least twice on each side, and
beat-to-beat changes in heart rate and blood pressure were
simultaneously recorded. Another 5 min was allowed for
recovery, and the patients were subsequently placed on the
upright position at 60°. Two minutes after assuming the
upright position, CSM was repeated as previously described.
If either presyncope or syncope was elicited, the patient was
promptly returned to the supine position and allowed to
recover spontaneously.
Head-up tilt protocol. Head-up tilt test (HUTT) was
performed in all patients regardless of the outcome of the
carotid sinus stimulation protocol. The subjects were placed
in the upright position at 60° for 15 min. If neither presyncope
nor syncope was not induced, an isoproterenol infusion was
started at a rate of 1 mg/min and titrated until an increase in
sinus cycle length of 25% was achieved. The maximum dose
infused did not exceed 3 mg/min, and the total duration of the
protocol was 30 min. Detailed description and validation of
this HUTT protocol has been previously reported (8).
Definitions. Carotid sinus hypersensitivity was defined as a
fall in systolic blood pressure $50 mm Hg and/or brady-
cardia $40 beats/min with or without asystole of 3 s or
more (1), associated with syncope or presyncope that re-
sembled the clinical presentation. Carotid sinus hypersen-
sitivity was further classified as: 1) cardioinhibitory type,
asystole $3 s not preceded by significant drop in blood
pressure; 2) vasodepressor type, fall in systolic blood pres-
sure $50 mm Hg associated with a decrease in heart rate
that is less than 10% of the pre-CSM heart rate; or 3) mixed
type, fall in systolic blood pressure $50 mm Hg associated
with bradycardia $40 beats/min. The provocation of syn-
cope or presyncope was necessary to establish the diagnosis
of CSH. A positive HUTT was defined as induction of
presyncope or syncope associated with a systolic blood
pressure #70 mm Hg and/or bradycardia, resembling the
clinical presentation (8). A modified version of the Euro-
pean classification for tilt-induced vasovagal syncope was
used (8,9). Type 1 or mixed response was characterized
by concurrent hypotension, systolic blood pressure
#70 mm Hg and ventricular rate $40 beats/min. Type 2a
cardioinhibitory response was indicated by a fall in ventric-
ular rate ,40 beats/min for more than 10 s or asystole
lasting more than 3 s. Blood pressure falls before the heart
rate falls. Type 2b cardioinhibitory response was an abrupt
fall in ventricular rate to ,40 beats/min for more than 10 s
Abbreviations and Acronyms
CSH 5 carotid sinus hypersensitivity
CSM 5 carotid sinus massage
ECG 5 electrocardiogram
HUTT 5 head-up tilt test
VF 5 ventricular fibrillation
VT 5 ventricular tachycardia
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or asystole lasting more than 3 s with no preceding drop in
blood pressure. Type 3 vasodepressor response was indicated
when ventricular rate did not fall more than 10% from its peak
at the time of syncope. Blood pressure falls before syncope.
Statistical analysis. Results are expressed as mean values 6
SD. One-way analysis of variance was used to compare the
difference between groups. Groups were compared by the
chi-square or Fisher exact test for categorical variables;
continuous variables were compared with paired (within
individual differences) or unpaired t tests where appropriate.
Multiple comparisons were analyzed with Scheffe´’s test.
Differences were considered significant if the null hypoth-
esis was rejected at a p level , 0.05.
RESULTS
All patients completed the study protocol. Clinical charac-
teristics were comparable within groups (Table 1). No
significant differences in the mean age, number of syncopal
episodes, baseline heart rate and blood pressure were ob-
served between groups. Similarly, the incidence of coronary
artery disease and other forms of structural heart disease
(i.e., cardiomyopathy, valvular disease) were not signifi-
cantly different between groups. Ten of the patients in the
group with syncope not related with CSH had documented
Chagas cardiomyopathy; the remaining six patients had
ischemic cardiomyopathy.
Pharmacological stimulation. The maximum changes
achieved in heart rate and systolic blood pressure after
administration of phenylephrine and nitroprusside bolus
injections are detailed in Table 2. The maximum change in
heart rate during nitroprusside injection was 13 6 8
beats/min in the CSH group compared with 24 6 10
beats/min in the unexplained syncope group, and 28 6 8
beats/min in the control group (p , 0.001 for control and
unexplained syncope vs. CSH). The maximum change in
heart rate during phenylephrine injection was 13 6 8
beats/min in the patients with CSH compared with 21 6 4
beats/min in the patients with unexplained syncope and
22 6 6 beats/min in the control group (p , 0.001 for CSH
group compared with unexplained syncope and control
group). Similarly, the maximum change in heart rate during
nitroprusside and phenylephrine injections was 11 6 6
beats/min and 9 6 3 beats/min, respectively, in the unre-
lated CSH syncope group (p , 0.001 compared with
unexplained syncope and control groups). Mean changes in
systolic blood pressure during nitroprusside bolus infusions
were 28 6 9 mm Hg in the CSH group compared with
35 6 8 mm Hg in the unexplained syncope group, 38 6
8 mm Hg in the control group and 33 6 8 mm Hg, in the
syncope unrelated to CSH group (p 5 0.07 compared with
CSH group). The mean change in systolic blood pressure
for the phenylephrine bolus infusions were 28 6 8 mm Hg
in the CSH group compared with 29 6 7 mm Hg in the
unexplained syncope group, 30 6 8 mm Hg in the control
group and 29 69 mm Hg in the syncope unrelated to CSH
group (p 5 0.80). Baroreceptor reflex sensitivity slopes were
calculated during blood pressure and heart rate changes
elicited throughout both pharmacological interventions and
individually during nitroprusside and phenylephrine injec-
tions (7). Mean overall baroreceptor slopes were signifi-
cantly reduced in the patients with CSH (3.3 6 1.6 ms/mm
Hg) compared with 12.6 6 2.2 ms/mm Hg in the unex-
plained syncope group, and 14.3 6 4 ms/mm Hg in the
Table 1. Clinical Characteristics
Age M/F CAD HBP CVD HCT CS OH
CSH [1] 65 6 12 38/10 15 (31%) 22 (45%) 5 (10%) 15 (31%) 4 (8.3%) 13 (27%)
CSH [2] 60 6 11 20/12 8 (25%) 12 (38%) 3 (9%) 8 (25%) 2 (6.3%) 3 (9.3%)*
Control 65 6 14 25/5 3 (10%) 8 (26%) 0 5 (16%) NA 2 (6.6%)
SNCSH 59 6 12 9/7 3 (16%) 6 (38%) 15 (94%) 3 (19%) NA 1 (6.3%)
*p , 0.01.
CAD 5 coronary artery disease; CS 5 carotid stenosis; CSH 5 carotid sinus hypersensitivity; CVD 5 cardiovascular disease;
HCT 5 hypercholesterolemia; HBP 5 high blood pressure; M/F 5 male/female; OH 5 orthostatic hypotension; SNCSH 5
syncope not related to CSH.
Table 2. Heart Rate and Blood Pressure Change After Pharmacologic, Mechanical and Orthostatic Stimulation of the Carotid Sinus
n
HR B
(beats/min)
DHR NT
(beats/min)
DHR PH
(beats/min)
DHR 0°
(beats/min)
DHR 60°
(beats/min)
DSBP 0°
(mm Hg)
DSBP 60°
(mm Hg)
CSH [1] 48 70 6 6 13 6 8* 13 6 8* 15 6 9 28 6 5* 18 6 8 56 6 24*
CSH [2] 32 72 6 5 24 6 10 21 6 4 10 6 8 10 6 4 10 6 6 14 6 10
Control 30 71 6 8 28 6 8 22 6 6 12 6 10 11 6 5 10 6 6 12 6 8
SNCSH 16 69 6 9 11 6 6* 9 6 3* 13 6 9 12 6 6 12 6 8 15 6 9
*p , 0.001 CSH [2] versus control group, and CSH [2] versus SNCSH group.
B 5 baseline; CSH 5 carotid sinus hypersensitivity; DHR 5 change in heart rate; NT 5 nitroprusside; PH 5 phenylephrine; DSBP 5 change in systolic blood pressure;
SNCSH 5 syncope not related to carotid sinus hypersensitivity.
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control group (Fig. 1; p , 0.001 for CSH vs. unexplained
syncope and control groups). Similarly, a marked reduction
in baroreflex slope was noted in the syncope unrelated to
CSH group 1.5 6 0.8 ms/mm Hg (p , 0.001 vs. unex-
plained syncope and control groups, p 5 0.05 vs. CSH).
Nitroprusside baroreflex slopes were as follows: 2.8 6
1.39 ms/mm Hg CSH group compared with 9.0 6
1.7 ms/mm Hg, 12.2 6 3.2 ms/mm Hg, 1.8 6 0.95 ms/mm
Hg in the unexplained syncope, control and syncope unre-
lated to CSH groups, respectively. Phenylephrine baroreflex
slopes were as follows: 4.4 6 2.2 ms/mm Hg in the CSH
group, compared with 12 6 2.5 ms/mm Hg, 13.2 6
3.2 ms/mm Hg and 1.2 6 0.75 ms/mm Hg in the
unexplained syncope, control and syncope unrelated to
CSH groups, respectively (p , 0.001 vs. control and
unexplained syncope groups, p , 0.05 vs. unrelated CSH
syncope group). Syncope was not provoked during pharma-
cological stimulation of the carotid sinus in any patient.
Mechanical and orthostatic stimulation. The heart rate
and blood pressure responses during CSM both in the
supine position and upright 60° positions are shown in
Table 2. Carotid sinus massage in the supine position was
associated with a maximum change in heart rate of 15 6 9
beats/min in the CSH group compared with 10 6 8
beats/min, 12 6 10 beats/min and 13 6 9 beats/min in the
unexplained syncope, control and syncope unrelated to
CSH groups, respectively (p . 0.05). The maximum
change in systolic blood pressure was 18 6 8 mm Hg in the
CSH group compared with 10 6 6 mm Hg, 10 6 4 mm Hg
and 12 6 8 mm Hg, in the unexplained syncope, control
and syncope unrelated to CSH groups, respectively (p 5
0.55 for CSH vs. other groups). In contrast, the maximum
change in heart rate elicited by CSM in the 60° upright
position were: 28 6 5 beats/min in the CSH group
compared with 10 6 4 beats/min, 11 6 5 beats/min and
12 6 6 beats/min in the unexplained syncope, control and
syncope unrelated to CSH groups, respectively (p , 0.001
for CSH vs. other groups). The maximum changes in
systolic blood pressure during 60° CSM were: 56 6
24 mm Hg in the CSH group, 14 6 10 mm Hg, 12 6
8 mm Hg and 15 6 9 mm Hg in the unexplained syncope,
control and syncope unrelated to CSH groups, respectively
(p , 0.001 for CSH vs. other groups).
Carotid sinus hypersensitivity was elicited by CSM in the
supine position in seven (8.7%) patients with unexplained
syncope, two (6.6%) controls and in one (6.3%) patient with
syncope unrelated to CSH. The response was significantly
improved by CSM at 60° in 48 (60%) patients with
unexplained syncope, compared with two (6.6%) controls
and one (6.3%) patient in the syncope unrelated to CSH
group. The response provoked by CSM was mixed in 25
(52%) patients, vasodepressor in 14 (29%) patients and
cardioinhibitory in the remaining 9 (18%) patients with
asystole ranging between 3 and 10 s. A mixed response was
provoked in the two patients from the control group as well
as the single patient from the unrelated CSH syncope
group. The type of response elicited by CSM in the supine
position was reproduced in all seven patients in the 60°
upright position; however, the severity of the response was
enhanced by orthostatic stress (Figs. 2 and 3). CSH was
predominantly elicited by right CSM in 34 (70%) patients
and by left CSM in the remaining 14 (30%) patients. A
cardioinhibitory response was provoked in 6 (12.5%) pa-
tients during right CSM, and in 3 (6%) patients during left
CSM, and a mixed response in 14 (29%) and 11 (23%)
patients, respectively. A vasodepressor response was elicited
in 8 (16%), and 6 (12.5%) patients, respectively. The
effectiveness of CSM to detect CSH in the supine position
was only 8.7% compared with 60% when CSM was per-
formed during upright tilt. This provided an increase in
diagnostic accuracy from 31% to 69%. Similarly, the positive
predictive value was improved from 77% to 96% when CSM
was performed during orthostatic stress. Head-up tilt test
was positive in 12 (25%) patients with CSH, 2 (6.6%)
controls and in none of the patients in which syncope
remained unexplained after testing. A positive HUTT was
also induced in one of the patients with syncope unrelated to
CSH. The mean time of onset of syncope or presyncope was
12 6 4.8 min, and the response elicited was type 1 (mixed)
in four (33%) patients and type 3 (vasodepressor) in the
remaining eight (67%) patients. The response provoked
during HUTT was concordant with the response provoked
by CSM in 9 of 12 (75%) patients.
DISCUSSION
The frequency of CSH as a cause of recurrent unexplained
syncope varies between 2% and 14% and may be related to
the routine assessment of CSM in patients referred for
syncope evaluation (2,10,11). Similarly, standardization of
the methodology of CSM has not been clearly established,
Figure 1. Mean baroreceptor slopes during pharmacologic inter-
vention. Shown are the mean baroreflex slopes in patients with
CSH (white bar), without CSH (dotted bar), control group (dark
meshed bar) and with syncope not related to CSH (hatched bar).
Baroreflex slopes obtained after bolus injections of nitroprusside
and phenylephrine are shown for each group from left to right.
*p 5 0.001.
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nor has the reproducibility of this test. The diagnostic value
of routine and systematic stimulation of the carotid sinus by
mechanical, pharmacological and orthostatic stress in pa-
tients with unexplained syncope has not been appropriately
assessed.
CSM during orthostatic stress. The major finding of the
present study was the significant increase in the diagnostic
yield of CSM when applied in the upright position. Carotid
sinus massage in the supine position identified only 7 (8.7%)
patients with CSH. In contrast, the routine assessment of
Figure 2. Response to CSM in the supine and upright position. (Top) The response to right (R) and left (L) sided. Carotid sinus massage
in the supine position. Right CSM elicited an asymptomatic drop in heart rate of 31 beats/min and a drop in systolic blood pressure of
25 mm Hg. (Bottom) The response to CSM in the upright 60° position. Right and left carotid massage reproducibly elicited a mean drop
in heart rate of 60 beats/min with a mean drop in systolic blood pressure of 58 mm Hg. The patient became markedly symptomatic with
syncope induced during the second right-sided massage. (L) Left carotid massage, (R) right carotid massage.
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CSM in the 60° upright position further identified CSH in
48 (60%) patients, increasing the diagnostic yield of CSM
by 52%. Additionally, the unrelated CSH syncope group
had the same rate of abnormal responses as the control
group (6.3%). These findings are in agreement with a recent
report from McIntosh et al. (12) in which more than half of
a series of elderly patients with recurrent syncope would
have been missed if CSM had not been performed in the
upright position, failing to identify CSH as the cause of the
syncopal episodes. The inclusion of a control group and a
group of patients with syncope not related to CSH permit-
ted us to calculate the sensitivity, specificity and predictive
values of CSM during orthostatic stress. It should be noted
that due to the lack of a true gold standard, the sensitivity
reported herein simply reflects the number of subjects in
which CSH was documented. Nonetheless, it is clear that
the diagnostic accuracy of CSM was markedly increased
from 31% in the supine position to 69% in the upright
position. Similarly, the positive predictive value was en-
hanced from 77% to 96% with excellent specificity (93%).
These findings support the recommendation to perform
CSM in both the supine and upright positions in older
patients with recurrent unexplained syncope.
Mechanisms. The mechanism underlying the additive ef-
fects of CSM and orthostatic stress are unclear. However,
neurocardiogenic syncope triggered by both HUTT and
CSH may share a common reflex pathway (13,14). This is
suggested by our observation that CSH and HUTT elicited
neurocardiogenic reflex responses in 25% of patients. Me-
chanical stimulation of the carotid sinus in combination
with orthostatic stress may sensitize both arterial and
Figure 3. Continuous ECG and blood pressure recording during right CSM (60°) in the same patient as in Figure 2. Right carotid
massage elicited abrupt asystole lasting 5.1 s associated with syncope.
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cardiopulmonary baroreceptors and contribute to the acti-
vation of the neurocardiogenic reflex. In the current study,
HUTT provoked syncope in 25% of patients with unex-
plained syncope and CSH. This finding further supports the
hypothesis that CSH and neurocardiogenic syncope may be
part of the spectrum of the same neurocardiogenic reflex and
may share common pathophysiologic processes. The inci-
dence of HUTT-induced neurocardiogenic syncope is low
compared with previous reports. However, this finding may
be related to the characteristics of the group assessed, which
was primarily older aged patients with fewer number of
syncopal episodes in the six months preceding evaluation
and which included patients with dizziness and presyncope
(8).
Another important finding is the significant reduction in
the baroreceptor reflex sensitivity slope we documented in
patients with syncope and CSH. These findings may be
related to an impaired baroreceptor adaptation to ortho-
static stress that may lead to inappropriate modulation of
muscle sympathetic nerve activity and further withdrawal of
sympathetic activity at the time of hypotension, potentiating
the development of syncope. Simultaneous recording of
muscle sympathetic activity at the time of syncope provoked
by CSM has documented abrupt sympathetic withdrawal at
the onset of hypotension (14). Further insight into this
mechanism may be provided by our finding of a reduced
response in blood pressure to bolus injections of nitroprus-
side, suggesting impaired efferent sympathetic baroreflex
traffic. O’Mahony (13) has recently proposed that medullary
a-2 receptor upregulation may be related to the pathophys-
iology of CSH. Our findings neither confirm nor disprove
this hypothesis. However, the decreased baroreceptor re-
sponse to vasoactive agents may be related to these findings.
A marked reduction in baroreflex gain (,2 ms/mm Hg) was
also noted in the group of patients with syncope not related
to CSH. This is no surprise, given the fact that the majority
of subjects in this group had documented VT/VF associated
with Chagas cardiomyopathy. We have previously reported
a significant reduction in baroreflex gain in sudden cardiac
death survivors with Chagas cardiomyopathy (15). Other
investigators have previously documented a high risk for
induction of VT/VF in postinfarction patients with reduced
baroreflex sensitivity ,3 ms/mm Hg (16–18). The patho-
physiologic role of reduced baroreflex gain in the CSH
group and the group with syncope not related to CSH
remains unclear. However, Landolina et al. (19) have
recently suggested that the hemodynamic tolerance to VT
may be related to impaired cardiovagal reflexes; namely,
markedly reduced baroreflex gain (,2 ms/mm Hg) was
associated with poorer hemodynamic tolerance of VT.
Impaired baroreflex gain may simply be a harbinger of
orthostatic intolerance in both CSH and VT/VF.
Additionally, our group and other investigators have
recently documented a significant reduction in baroreceptor
gain in patients with neurocardiogenic syncope provoked by
HUTT (20–22), further supporting these findings. How-
ever, Morley et al. (23) and Dehn et al. (24) have reported
opposite findings, namely increased baroreceptor gain in
patients with CSH. The nature of this discrepancy is
unclear and may be attributed to differences in the meth-
odology used for assessment of baroreceptor reflex sensitiv-
ity.
Syncope or presyncope was not provoked in any of our
patients during pharmacologic stimulation. This finding is
consistent with Morley et al. (23), who did not report
inducing syncope or presyncope in any of their patients
during phenylephrine infusion. Similarly, Dehn et al. (24)
did not report the induction of syncope of presyncope
during carotid stimulation using a neck chamber. The
explanation for this finding is unclear; however, it is possible
that both pharmacologic and mechanical stimulation with
the neck chamber produce a less intense stimulation of the
carotid sinus than direct external pressure. Similarly, in our
study and in previously reported studies (23,24), pharma-
cologic and mechanical stimulation with the neck chamber
have been performed exclusively in the supine position.
Based on our findings, it is possible that both pharmacologic
and mechanical stimulation with the neck chamber during
orthostatic stress may increase the diagnostic yield of these
methods.
The response obtained during CSM was primarily mixed
in 52%, vasodepressor in 29% and only 18% presenting as
cardioinhibitory CSH. These findings contrast with previ-
ous reports in which the cardioinhibitory response was
documented in up to 80% of patients (2–5). Most previous
studies have reported that vasodepressor responses account
for only 5% to 10% of CSH cases (1–5,25,26). The
explanation for this difference may be due to the lack of
continuous noninvasive blood pressure recordings in the
earlier reports as well as absence of simultaneous CSM
during orthostatic stress (12). Gaggioli et al. (27) have
recently highlighted the importance of beat-to-beat blood
pressure measurements during CSM and reported a vaso-
depressor response in 84% of patients with CSH. We
observed a vasodepressor response in 29% of patients;
however, we did not perform CSM after administration of
atropine, possibly underestimating the incidence of the
vasodepressor response.
Study limitations. The lack of a gold standard method for
the diagnosis of syncope limits the findings of CSH as the
exclusive cause of syncope. Electrophysiologic evaluation
was not performed in all subjects, rendering the possibility
that other potential causes of syncope were not excluded.
Elderly patients are more likely to have multiple causes of
syncope coexisting. Similarly, CSM was not repeated after
the administration of atropine, possibly underestimating the
frequency of the vasodepressor response. Nonetheless, it is
unlikely that these limitations invalidate our findings.
Conclusions. CSH was documented in 68% of patients
with unexplained syncope, 8% in the supine position and
60% in the upright position, referred for assessment of
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unexplained syncope or presyncope. Combined orthostatic
stress and mechanical stimulation of the carotid sinus
markedly increased the diagnostic yield of CSM. Decreased
baroreceptor gain was documented in patients with CSH
and may play a role in the pathophysiology of CSH.
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